SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form F-3 - Registration statement by foreign private issuers:
SEC Accession No. 0001178913-18-003211
Filing Date
2018-12-26
Accepted
2018-12-26 16:11:29
Documents
11

Document Format Files

Seq Description Document Type Size
1 F-3 zk1822405.htm F-3 188757
2 OPINION OF YIGAL ARNON & CO., ISRAELI COUNSEL TO THE REGISTRANT exhibit_5-1.htm EX-5.1 40776
3 OPINION OF MAYER BROWN LLP, U.S. COUNSEL TO THE REGISTRANT exhibit_5-2.htm EX-5.2 13495
4 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM exhibit_23-1.htm EX-23.1 3866
5 image0.jpg GRAPHIC 78088
6 image00002.jpg GRAPHIC 3906
7 image00003.jpg GRAPHIC 22619
8 image00004.jpg GRAPHIC 955
9 image00005.jpg GRAPHIC 2251
10 image00008.jpg GRAPHIC 2375
11 image00009.jpg GRAPHIC 5832
  Complete submission text file 0001178913-18-003211.txt   408548
Mailing Address 2 HAMA-AYAN STREET MODI-IN TECHNOLOGY PARK MODI-IN L3 7177871
Business Address 2 HAMA-AYAN STREET MODI-IN TECHNOLOGY PARK MODI-IN L3 7177871 972-2-548-9100
BioLineRx Ltd. (Filer) CIK: 0001498403 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: F-3 | Act: 33 | File No.: 333-229021 | Film No.: 181252792
SIC: 2834 Pharmaceutical Preparations